當(dāng)前位置: 首頁 - 產(chǎn)品目錄 - 小分子抑制劑
2-Deoxy-D-glucose (2-DG)
貨號 | ICE1201 | 售價(元) | 567 |
規(guī)格 | 1g | CAS號 | 154-17-6 |
- 產(chǎn)品簡介
- 相關(guān)產(chǎn)品
產(chǎn)品信息
貨號 |
產(chǎn)品名稱 |
規(guī)格 |
價格/元 |
ICE1201-0001G |
2-Deoxy-D-glucose 2-脫氧-D-葡萄糖 |
1g |
567 |
ICE1201-0005G |
2-Deoxy-D-glucose 2-脫氧-D-葡萄糖 |
5g |
2298 |
ICE1201-0025G |
2-Deoxy-D-glucose 2-脫氧-D-葡萄糖 |
25g |
詢價 |
2-脫氧-D-葡萄糖(2-Deoxy-D-glucose, 2-DG),一種不可代謝的葡萄糖類似物,通過作用于己糖激酶(糖酵解的限速步驟)來抑制糖酵解。2-DG被己糖激酶磷酸化生成2-DG-P,后者不能被磷酸葡萄糖異構(gòu)酶進(jìn)一步代謝,進(jìn)而引起2-DG-P在細(xì)胞內(nèi)的累積和細(xì)胞內(nèi)ATP的耗盡。體外缺氧模型中,2-DG導(dǎo)致細(xì)胞周期抑制和細(xì)胞死亡,誘導(dǎo)自噬,增加ROS生成和活化AMPK。體內(nèi)動物模型中阻斷腫瘤細(xì)胞生長。
產(chǎn)品特性
1) CAS NO:154-17-6
2) 化學(xué)名:(4R,5S,6R)-6-(Hydroxymethyl)oxane-2,4,5-triol
3) 同義名:2-deoxyglucose; 2-Deoxy-D-arabinohexose; D-Arabino-2-deoxyhexose; Ba 2758; NSC 15193; 2-脫氧葡萄糖;2-去氧-D-葡萄糖;D-2-脫氧葡萄糖;
4) 分子式:C6H12O5
5) 分子量:164.16
6) 外觀:白色至類白色固體
7) 純度:>98%
8) 溶解性:溶于DMSO(20mg/ml)、H2O(30mg/ml)、PBS, pH 7.2 (10mg/ml)
保存與運(yùn)輸方法
保存:2-8℃避光干燥保存,至少2年有效。
運(yùn)輸:室溫運(yùn)輸。
注意事項(xiàng)
1) 本品儲存液置于≤-20℃避光保存,盡量避免反復(fù)凍融。通常情況下,-20℃至少一個月穩(wěn)定,-80℃至少6個月穩(wěn)定。
2) 本品僅用作科研用途,絕不可用于臨床診斷或治療藥物,絕不可用做食品或藥品。
3)為了您的安全和健康,請穿實(shí)驗(yàn)服并戴一次性手套操作。
儲存液配制
質(zhì)量 濃度 |
1mg |
5mg |
10mg |
1mM |
6.0916 mL |
30.4581 mL |
60.9162mL |
5mM |
1.2183mL |
6.0916 mL |
12.1832mL |
10mM |
0.6092 mL |
3.0458 mL |
6.0916 mL |
50mM |
0.1218 mL |
0.6092 mL |
1.2183 mL |
使用方法【源自文獻(xiàn),僅作參考】
文獻(xiàn)1,Yan J et al. The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells. Cancer Res. 2005 Aug 1;65(15):7023-30. PMID: 16061689
體外研究(細(xì)胞實(shí)驗(yàn)):
細(xì)胞類型(Cell types):MCF-7 cells
實(shí)驗(yàn)方法(Assay):For cell growth assay, MCF-7 cells were plated at 3 × 104 cells per well in flat-bottomed 96-well plates in 100 μL of culture medium. After 24 hours, cells were fed with fresh medium including 2-DG at doses of 0, 4, 8, or 16 mmol/L. At days 1, 3, and 5 after 2-DG exposure, cells were fixed with 1% glutaraldehyde, replaced with PBS, and stored at 4°C. At the end of an experiment, all of the plates were stained with 0.02% aqueous crystal violet for 30 minutes and rinsed with deionized water. After redissolving the bound crystal violet in 70% ethanol, the absorbance was determined at 590 nm.
實(shí)驗(yàn)結(jié)果(Result):Cell growth was significantly inhibited by 2-DG at doses of 4, 8, or 16 mmol/L for 1, 3, or 5 days in a dose- and time-dependent manner (P < 0.001).
體內(nèi)研究(動物模型):
動物模型(Animal Model):At 21 days of age, rats were injected with 50 mg 1-methyl-1-nitrosourea per kilogram of body weight (i.p.). Six days following carcinogen injection, all rats were randomized into one of three groups, 30 rats per group, and werefed ad libitum AIN-93G diet containing0.0%, 0.02%, or 0.03% (w/w) 2-DGfor 5 weeks.
實(shí)驗(yàn)結(jié)果(Result):2-DG decreased the incidence and multiplicity of mammary carcinomas and prolonged cancer latency (P < 0.05). The 0.02% dose of 2-DG had no effect on circulating levels of glucose, insulin, insulin-like growth factor-I, IGF binding protein-3, leptin, or body weight gain.
文獻(xiàn)2,Wang H et al. 2-deoxy-D-glucose enhances anesthetic effects in mice. Anesth Analg. 2015 Feb; 120(2):312-9. PMID: 25390277
體內(nèi)研究(動物模型):
動物模型(Animal Model):Female Sprague-Dawley rats at 20 days of age
配制方法(Formulation):2-DGwasdiluted insaline.
實(shí)驗(yàn)方法(Assay):2-DG (1000 mg/kg), 3-NP (50 mg/kg),30 or saline was injected [intraperitoneally (ip)] 5 minutes before isoflurane anesthesia.Idebenone (200 mg/kg) or L-carnitine (100 mg/kg) was injected 15 minutes before isoflurane anesthesia (10 minutes before treatment with 2-DG or 3-NP).
實(shí)驗(yàn)結(jié)果(Result):2-DG enhances isoflurane-induced loss of righting reflex (LORR) in mice.